FDA approves medication for treatment of thyroid eye disease

By Rebecca Moroney on January 25, 2020

The FDA has approved teprotumumab, to treat thyroid eye disease in adults. This new treatment has been shown to reverse the effects of the disease. Read more about this new trreatment at https://www.healio.com/endocrinology/thyroid/news/online/%7Bba53d7c2-3140-4550-b027-63210804d2fb%7D/fda-approves-teprotumumab-for-thyroid-eye-disease.

Related to This

Contact Us Today

Rate, Review & Explore

Social Accounts Sprite

West Orange Office

101 Old Short Hills Rd
Ste 430
West Orange, NJ 07052

Open Today 8:00am - 4:00pm

Open Two Saturdays a Month. Call for Hours

Livingston Office

315 E Northfield Rd
#2b
Livingston, NJ 07039

Open Today 8:00am - 4:00pm